ESLA
ESLA
NASDAQ · Biotechnology

Estrella Immunopharma Inc

$1.45
+0.13 (+9.85%)
As of Feb 8, 2:17 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +940.0% upside
Low Target $11.92
Average Target $15.08
High Target $19.61
Current Price $1.45
Current
$1.45
Target
$15.08
$11.92 $15.08 avg $19.61
Scenario Analysis
Bear Case
$11.92
722.1%
Low target
Base Case
$15.08
+940.0%
Avg target
Bull Case
$19.61
+1,252.4%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$17.15
-91.5% from high
52-Week Low
$7.69
+-81.1% from low
Target vs 52W High
$15.08
-12.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%